Akso Health Group ADR (AHG)vs111 Inc (YI)
AHG
Akso Health Group ADR
$2.37
+4.37%
HEALTHCARE · Cap: $807.33M
YI
111 Inc
$6.29
-1.02%
HEALTHCARE · Cap: $58.07M
Smart Verdict
WallStSmart Research — data-driven comparison
111 Inc generates 91819% more annual revenue ($13.58B vs $14.78M). AHG leads profitability with a 0.0% profit margin vs -0.5%. YI earns a higher WallStSmart Score of 31/100 (F).
AHG
Avoid24
out of 100
Grade: F
YI
Avoid31
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
4.2% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -10.9% — below average capital efficiency
Revenue declined 16.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : YI
The strongest argument for YI centers on Debt/Equity, Altman Z-Score.
Bear Case : AHG
The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.
Bear Case : YI
The primary concerns for YI are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
AHG profiles as a value stock while YI is a turnaround play — different risk/reward profiles.
YI carries more volatility with a beta of 0.64 — expect wider price swings.
AHG is growing revenue faster at 4.2% — sustainability is the question.
YI generates stronger free cash flow (38M), providing more financial flexibility.
Bottom Line
YI scores higher overall (31/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.
Visit Website →111 Inc
HEALTHCARE · MEDICAL DISTRIBUTION · China
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?